These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28178902)

  • 1. Nanobiomaterials' applications in neurodegenerative diseases.
    Silva Adaya D; Aguirre-Cruz L; Guevara J; Ortiz-Islas E
    J Biomater Appl; 2017 Feb; 31(7):953-984. PubMed ID: 28178902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting nanoparticles across the blood-brain barrier with monoclonal antibodies.
    Loureiro JA; Gomes B; Coelho MA; do Carmo Pereira M; Rocha S
    Nanomedicine (Lond); 2014 Apr; 9(5):709-22. PubMed ID: 24827845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles and blood-brain barrier: the key to central nervous system diseases.
    Domínguez A; Suárez-Merino B; Goñi-de-Cerio F
    J Nanosci Nanotechnol; 2014 Jan; 14(1):766-79. PubMed ID: 24730296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
    Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
    Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
    Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
    Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Nanocomposites and Nanoparticles in Treating Neurodegenerative Disorders.
    Fatima J; Siddique YH
    CNS Neurol Disord Drug Targets; 2024; 23(10):1217-1233. PubMed ID: 38288843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in the treatment of neurodegenerative disorders employing nanotechnology.
    Modi G; Pillay V; Choonara YE
    Ann N Y Acad Sci; 2010 Jan; 1184():154-72. PubMed ID: 20146696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Nanomaterials in Neurodegenerative Diseases.
    Cui W; Fu W; Lin Y; Zhang T
    Curr Stem Cell Res Ther; 2021; 16(1):83-94. PubMed ID: 32213159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of nanodiagnostics and nanotherapy to CNS diseases.
    Zhang W; Wang W; Yu DX; Xiao Z; He Z
    Nanomedicine (Lond); 2018 Sep; 13(18):2341-2371. PubMed ID: 30088440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.
    Toman P; Lien CF; Ahmad Z; Dietrich S; Smith JR; An Q; Molnár É; Pilkington GJ; Górecki DC; Tsibouklis J; Barbu E
    Acta Biomater; 2015 Sep; 23():250-262. PubMed ID: 25983313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontier View on Nanotechnological Strategies for Neuro-therapy.
    Azhar A; Ashraf GM; Zia Q; Ansari SA; Perveen A; Hafeez A; Saeed M; Kamal MA; Alexiou A; Ganash M; Yarla NS; Baeesa SS; Alfiky MM; Bajouh OS
    Curr Drug Metab; 2018; 19(7):596-604. PubMed ID: 29512448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobiotechnology and its applications in drug delivery system: a review.
    Khan I; Khan M; Umar MN; Oh DH
    IET Nanobiotechnol; 2015 Dec; 9(6):396-400. PubMed ID: 26647817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for brain-targeting liposomal delivery of small hydrophobic molecules in the treatment of neurodegenerative diseases.
    Wang ZY; Sreenivasmurthy SG; Song JX; Liu JY; Li M
    Drug Discov Today; 2019 Feb; 24(2):595-605. PubMed ID: 30414950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nanomaterials for clinical neuroscience.
    Gilmore JL; Yi X; Quan L; Kabanov AV
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):83-94. PubMed ID: 18210200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma Multiforme and Lipid Nanocapsules: A Review.
    Aparicio-Blanco J; Torres-Suárez AI
    J Biomed Nanotechnol; 2015 Aug; 11(8):1283-311. PubMed ID: 26295134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics.
    Lamptey RNL; Chaulagain B; Trivedi R; Gothwal A; Layek B; Singh J
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.
    Poovaiah N; Davoudi Z; Peng H; Schlichtmann B; Mallapragada S; Narasimhan B; Wang Q
    Nanoscale; 2018 Sep; 10(36):16962-16983. PubMed ID: 30182106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
    Rajpoot K
    Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.